BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 7268059)

  • 21. [Abnormal accumulation of 99mTc-hydroxymethylene diphosphonate in the gallbladder 5 cases and their clinical study--].
    Bussaka H; Takahashi M
    Kaku Igaku; 1982 Jun; 19(5):817-21. PubMed ID: 7176194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Horseshoe kidney incidentally detected by 99mTc-MDP bone scintigraphy: report of 2 cases (author's transl)].
    Bussaka H; Takahashi M
    Rinsho Hoshasen; 1982 May; 27(5):581-3. PubMed ID: 6213796
    [No Abstract]   [Full Text] [Related]  

  • 23. [Radiochemical purity and stability of 99mTc-MDP for bone scintigraphy (author's transl)].
    Yoshino T; Watanabe N; Kawahara Y; Okada K; Nishimura I
    Radioisotopes; 1980 Aug; 29(8):398-400. PubMed ID: 6451900
    [No Abstract]   [Full Text] [Related]  

  • 24. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extraosseous accumulation of 99mTc-phosphate complexes (author's transl)].
    Takebayashi S; Ono Y; Odagiri K; Nakamori A; Asakura K; Matsui K; Tanaka T; Oikawa Y; Yamamoto Y
    Kaku Igaku; 1981 Nov; 18(9):1207-15. PubMed ID: 6461788
    [No Abstract]   [Full Text] [Related]  

  • 26. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
    Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
    J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early dynamic bone-imaging as an indicator of osseous blood flow and factors affecting the uptake of 99mTc hydroxymethylene diphosphonate in healing bone.
    Nutton RW; Fitzgerald RH; Kelly PJ
    J Bone Joint Surg Am; 1985 Jun; 67(5):763-70. PubMed ID: 3997929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of bone scan using Tc-99m methylene diphosphonate (author's transl)].
    Kado B; Nakajima T; Sakura M; Sasaki Y; Nagai T
    Kaku Igaku; 1979 Feb; 16(1):95-103. PubMed ID: 439497
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone scanning after marrow biopsy: concise communication.
    Tyler JL; Powers TA
    J Nucl Med; 1982 Dec; 23(12):1085-7. PubMed ID: 7143090
    [No Abstract]   [Full Text] [Related]  

  • 31. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K; Aigner S; Bühler M; Umbach I
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)].
    Hamada S; Miyamura T; Okimura T; Yamamoto T; Nishiki M; Miyatani H; Kobayashi M; Tonami H; Takarada A; Yamagishi T; Higashi K; Chatani T
    Rinsho Hoshasen; 1981 Aug; 26(8):897-900. PubMed ID: 6457187
    [No Abstract]   [Full Text] [Related]  

  • 33. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
    Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
    J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between bone-background ratio and serum phosphorus level in bone imagine on hemodialysis patients (author's transl)].
    Yamashita M; Aoki T; Murakami K
    Radioisotopes; 1982 Jan; 31(1):29-31. PubMed ID: 6461887
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A; Hutchison N
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse pulmonary ossification detected by bone scanning with Tc-99m hydroxymethylene diphosphate.
    Saks DA; McClees EC; Fajman WA; Hollinger WM; Gilman MJ
    Clin Nucl Med; 1984 Oct; 9(10):594-5. PubMed ID: 6435921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The kidneys and urinary tracts, as demonstrated by skeletal scintigraphy with 99m technetium-methyl diphosphonate (author's transl)].
    Crone-Münzebrock W
    Rofo; 1980 Jul; 133(1):75-8. PubMed ID: 6451535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.